A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma plc shares subscribed with option rights

Herantis Pharma plc shares subscribed with option rights Herantis Pharma plc. Stock exchange release 10 November 2014, 11.00 am 4000…

Read More

Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops

Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops Herantis Pharma plc. Company release…

Read More

Interim report January 1-June 30, 2014: Pharmaceutical development programs advancing as planned - successful share issue enables progress according to strategy

Highlights in January-June 2014: Herantis Pharma Group was formed through the merger of two Finnish pharmaceutical development companies on April…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.